Literature DB >> 18458809

Excellent response to letrozole in brain metastases from breast cancer.

S Goyal1, T Puri, P K Julka, G K Rath.   

Abstract

Breast cancer with multiple parenchymal brain metastases carries an extremely poor outcome. Cranial radiotherapy improves survival by only a few months and the role of systemic therapy is marginal and largely unexplored. We report a patient with recurrent carcinoma of breast presenting with multiple bilateral cervical nodes and brain metastases manifesting as a right hemiparesis and facial nerve palsy, who was treated with palliative whole brain irradiation and letrozole. At the follow up at 20 months, neurological function had fully recovered, and both cerebral and extracerebral lesions had completely resolved, with calcification of the cerebral lesions. This report suggests that letrozole has beneficial effects both in extracranial and intracranial disease in hormone responsive metastatic breast cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18458809     DOI: 10.1007/s00701-008-1576-z

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  7 in total

1.  Multiple calcified brain metastases in a man with invasive ductal breast cancer.

Authors:  Nadine Ressl; Stefan Oberndorfer
Journal:  BMJ Case Rep       Date:  2015-10-15

Review 2.  Systemic Therapy of Central Nervous System Metastases of Breast Cancer.

Authors:  José Pablo Leone; Nancy U Lin
Journal:  Curr Oncol Rep       Date:  2019-04-08       Impact factor: 5.075

3.  Effects of aromatase inhibition versus gonadectomy on hippocampal complex amyloid pathology in triple transgenic mice.

Authors:  Cassia R Overk; Pei-Yi Lu; Yue-Ting Wang; Jaewoo Choi; James W Shaw; Gregory R Thatcher; Elliott J Mufson
Journal:  Neurobiol Dis       Date:  2011-09-16       Impact factor: 5.996

Review 4.  Developmental therapeutics for patients with breast cancer and central nervous system metastasis: current landscape and future perspectives.

Authors:  R Costa; B A Carneiro; D A Wainwright; C A Santa-Maria; P Kumthekar; Y K Chae; W J Gradishar; M Cristofanilli; F J Giles
Journal:  Ann Oncol       Date:  2017-01-01       Impact factor: 51.769

5.  Efficacy of arginine depletion by ADI-PEG20 in an intracranial model of GBM.

Authors:  Justyna Magdalena Przystal; Nabil Hajji; Combiz Khozoie; Alexander Renziehausen; Qingyu Zeng; Fernando Abaitua; Amin Hajitou; Keittisak Suwan; Elizabeth Want; John Bomalaski; Peter Szlosarek; Kevin O'Neill; Tim Crook; Nelofer Syed
Journal:  Cell Death Dis       Date:  2018-12-13       Impact factor: 8.469

Review 6.  Breast cancer brain metastases: a review of the literature and a current multidisciplinary management guideline.

Authors:  M J Gil-Gil; M Martinez-Garcia; A Sierra; G Conesa; S Del Barco; S González-Jimenez; S Villà
Journal:  Clin Transl Oncol       Date:  2013-11-26       Impact factor: 3.405

Review 7.  Breast cancer brain metastases: the last frontier.

Authors:  José Pablo Leone; Bernardo Amadeo Leone
Journal:  Exp Hematol Oncol       Date:  2015-11-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.